Naperol Investments Ltd

Naperol Investments Ltd

₹ 656 -2.97%
11 May 11:46 a.m.
About

Incorporated in 1954, National Peroxide Ltd is engaged in Investment and Leasing business[1]

Key Points

Services Offered:[1]
a) Manufacturing, distribution and dealing
of peroxygen chemicals
b) Making long term investments and corporate lending directly and/or through its wholly owned subsidiary viz., the Transferor Company.

  • Market Cap 377 Cr.
  • Current Price 656
  • High / Low 1,212 / 490
  • Stock P/E 35.3
  • Book Value 1,609
  • Dividend Yield 1.37 %
  • ROCE 1.07 %
  • ROE 1.03 %
  • Face Value 10.0

Pros

  • Company is almost debt free.
  • Stock is trading at 0.41 times its book value
  • Company is expected to give good quarter
  • Company has been maintaining a healthy dividend payout of 51.3%

Cons

  • Tax rate seems low
  • Company has a low return on equity of 0.71% over last 3 years.
  • Working capital days have increased from -5.93 days to 226 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
0 0 0 1 0 0 2 1 16 3 3 1 20
0 1 0 0 1 1 0 2 6 3 3 1 8
Operating Profit -0 -0 -0 1 -1 -0 1 -0 11 0 0 -0 11
OPM % -36% -154% -14% 54% -248% -129% 76% -24% 65% 1% 1% -12% 57%
0 0 0 0 0 0 0 0 0 0 0 0 -0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit before tax -0 -0 -0 1 -1 -0 2 -0 11 0 0 -0 11
Tax % 30% -26% -50% 9% -24% -11% 24% -26% 8% 27% 125% 383% -1%
-0 -0 -0 1 -1 -0 1 -0 10 0 -0 -1 11
EPS in Rs -0.21 -0.56 -0.04 0.93 -0.96 -0.58 2.33 -0.46 17.21 0.14 -0.02 -1.04 19.68
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
196 233 233 306 402 208 226 232 2 2 20 27
174 197 163 161 175 166 170 209 2 3 8 16
Operating Profit 22 36 70 145 226 42 56 23 -0 -1 12 11
OPM % 11% 15% 30% 47% 56% 20% 25% 10% -13% -32% 58% 41%
6 7 -2 11 19 1 -15 10 376 0 0 0
Interest 5 5 2 1 1 3 13 9 0 0 0 0
Depreciation 7 9 9 9 9 11 18 17 0 0 0 0
Profit before tax 16 29 57 146 235 29 12 7 376 -1 12 11
Tax % 62% 37% 34% 35% 35% 40% -76% 32% 0% -41% 10% 4%
6 18 38 95 153 17 21 5 375 -0 11 11
EPS in Rs 10.93 31.53 66.46 166.88 268.47 30.47 36.51 8.93 658.33 -0.65 18.51 18.75
Dividend Payout % 46% 32% 52% 39% 24% 41% 35% 56% 0% 0% 49% 105%
Compounded Sales Growth
10 Years: -19%
5 Years: -35%
3 Years: 142%
TTM: 33%
Compounded Profit Growth
10 Years: -6%
5 Years: -21%
3 Years: 260%
TTM: 1%
Stock Price CAGR
10 Years: 5%
5 Years: -18%
3 Years: -13%
1 Year: -26%
Return on Equity
10 Years: 6%
5 Years: 1%
3 Years: 1%
Last Year: 1%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 6 6 6 6 6 6 6 6 6 6 6 6
Reserves 203 214 368 503 609 481 583 532 552 1,049 1,158 911
73 30 11 0 80 161 125 94 0 0 0 0
62 60 55 76 88 94 71 63 1 23 42 3
Total Liabilities 344 310 440 585 783 742 785 694 559 1,078 1,205 920
187 180 178 170 166 372 342 338 0 0 0 0
CWIP 4 3 2 6 75 0 3 4 0 0 0 0
Investments 10 7 170 253 192 177 268 282 547 1,065 1,190 895
143 120 90 156 350 193 172 71 12 13 16 24
Total Assets 344 310 440 585 783 742 785 694 559 1,078 1,205 920

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
21 22 59 94 148 16 61 9 1 1 -3 -9
-75 30 -31 -56 -175 -38 -7 34 1 0 11 8
54 -51 -28 -35 35 14 -49 -49 -3 -1 -6 -2
Net Cash Flow 0 -0 -0 3 8 -9 4 -6 -0 1 2 -3
Free Cash Flow -15 21 53 84 69 -83 40 -8 1 1 -3 -9
CFO/OP 117% 81% 105% 93% 100% 62% 118% 52% -646% -313% -29% -69%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 69 51 52 64 28 57 38 30 193 0 74 101
Inventory Days 76 65 66 65 134 98 87 87 0 0
Days Payable 120 83 115 90 101 75 102 41
Cash Conversion Cycle 25 33 4 39 61 80 23 76 193 0 74 101
Working Capital Days 107 101 62 115 229 230 197 42 -85 -302 59 226
ROCE % 9% 13% 21% 33% 39% 5% 6% 1% -0% -0% 1% 1%

Insights

In beta
Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Capacity Utilization - Hydrogen Peroxide
%

Log in to view insights

Please log in to see hidden values.

Login
Installed Capacity - Hydrogen Peroxide (50% w/w)
MTPA
Production Volume - Hydrogen Peroxide (50% w/w)
MT
Power Consumption per Unit of Production
KWH/MT
Sales Volume - Hydrogen Peroxide (50% w/w)
MT
Domestic Market Share - Hydrogen Peroxide
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
70.76% 70.77% 70.77% 70.77% 70.77% 70.77% 70.77% 70.77% 70.77% 70.77% 70.77% 70.77%
0.00% 0.07% 0.00% 0.00% 0.67% 1.91% 1.98% 1.98% 1.76% 1.76% 1.76% 1.76%
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.02% 0.02% 0.02% 0.02% 0.02% 0.01%
29.23% 29.16% 29.23% 29.22% 28.55% 27.31% 27.24% 27.23% 27.46% 27.46% 27.46% 27.47%
No. of Shareholders 18,63219,05419,80918,93218,18815,77515,54415,71715,68015,41515,22614,913

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents